Atricure Stock Alpha and Beta Analysis
| ATRC Stock | USD 40.18 0.24 0.59% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AtriCure. It also helps investors analyze the systematic and unsystematic risks associated with investing in AtriCure over a specified time horizon. Remember, high AtriCure's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AtriCure's market risk premium analysis include:
Beta 0.95 | Alpha 0.17 | Risk 2.7 | Sharpe Ratio 0.11 | Expected Return 0.29 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out AtriCure Backtesting, AtriCure Valuation, AtriCure Correlation, AtriCure Hype Analysis, AtriCure Volatility, AtriCure History and analyze AtriCure Performance. AtriCure Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AtriCure market risk premium is the additional return an investor will receive from holding AtriCure long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AtriCure. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AtriCure's performance over market.| α | 0.17 | β | 0.95 |
AtriCure expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AtriCure's Buy-and-hold return. Our buy-and-hold chart shows how AtriCure performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.AtriCure Market Price Analysis
Market price analysis indicators help investors to evaluate how AtriCure stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AtriCure shares will generate the highest return on investment. By understating and applying AtriCure stock market price indicators, traders can identify AtriCure position entry and exit signals to maximize returns.
AtriCure Return and Market Media
The median price of AtriCure for the period between Thu, Oct 2, 2025 and Wed, Dec 31, 2025 is 36.17 with a coefficient of variation of 8.06. The daily time series for the period is distributed with a sample standard deviation of 2.94, arithmetic mean of 36.47, and mean deviation of 2.43. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | AtriCure to Participate in Upcoming Investor Conferences | 10/27/2025 |
2 | AtriCure Losses Worsen 12.8 percent Annually, Challenging Bullish Profitability Narratives | 10/31/2025 |
3 | Head-To-Head Comparison AtriCure versus PositiveID | 11/21/2025 |
4 | Disposition of 5033 shares by Wehrwein Sven of AtriCure at 19.95 subject to Rule 16b-3 | 11/24/2025 |
5 | Is It Time To Reassess AtriCure After Its Recent Share Price Rebound In 2025 | 12/03/2025 |
6 | Are Medical Stocks Lagging AtriCure This Year | 12/08/2025 |
7 | Disposition of 4000 shares by Michael Carrel of AtriCure subject to Rule 16b-3 | 12/10/2025 |
8 | AtriCure Clears Technical Benchmark, Hitting 80-Plus RS Rating | 12/11/2025 |
9 | JP Morgan Raises AtriCure Price Target to 48 ATRC Stoc - GuruFocus | 12/16/2025 |
10 | AtriCure Is Up 6.32 percent in One Week What You Should Know | 12/19/2025 |
11 | Analysts See an Over 26 percent Upside in AtriCure | 12/22/2025 |
12 | Has AtriCure Outpaced Other Medical Stocks This Year | 12/24/2025 |
13 | AtriCure Assessing Valuation After First-In-Human PFARFA Procedures and Renewed Analyst Optimism | 12/26/2025 |
About AtriCure Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AtriCure or other stocks. Alpha measures the amount that position in AtriCure has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 47.17 | 48.0 | 47.33 | 56.96 | PTB Ratio | 4.44 | 3.55 | 3.11 | 3.71 |
AtriCure Upcoming Company Events
As portrayed in its financial statements, the presentation of AtriCure's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AtriCure's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AtriCure's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AtriCure. Please utilize our Beneish M Score to check the likelihood of AtriCure's management manipulating its earnings.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with AtriCure
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out AtriCure Backtesting, AtriCure Valuation, AtriCure Correlation, AtriCure Hype Analysis, AtriCure Volatility, AtriCure History and analyze AtriCure Performance. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
AtriCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.